Literature DB >> 33382958

Diaphragm neuromuscular transmission failure in a mouse model of an early-onset neuromotor disorder.

Matthew J Fogarty1,2, Joline E Brandenburg3,4, Gary C Sieck1,3.   

Abstract

The spa transgenic mouse displays spasticity and hypertonia that develops during the early postnatal period, with motor impairments that are remarkably similar to symptoms of human cerebral palsy. Previously, we observed that spa mice have fewer phrenic motor neurons innervating the diaphragm muscle (DIAm). We hypothesize that spa mice exhibit increased susceptibility to neuromuscular transmission failure (NMTF) due to an expanded innervation ratio. We retrogradely labeled phrenic motor neurons with rhodamine and imaged them in horizontal sections (70 µm) using confocal microscopy. Phrenic nerve-DIAm strip preparations from wild type and spa mice were stretched to optimal length, and force was evoked by phrenic nerve stimulation at 10, 40, or 75 Hz in 330-ms duration trains repeated each second (33% duty cycle) across a 120-s period. To assess NMTF, force evoked by phrenic nerve stimulation was compared to force evoked by direct DIAm stimulation superimposed every 15 s. Total DIAm fiber number was estimated in hematoxylin and eosin-stained strips. Compared to wild type, spa mice had over twofold greater NMTF during the first stimulus train that persisted throughout the 120 s period of repetitive activation. In both wild type and spa mice, NMTF was stimulation-frequency dependent. There was no difference in neuromuscular junction morphology or the total number of DIAm fibers between wild type and spa mice, however, there was an increase innervation ratio (39%) in spa mice. We conclude that early-onset developmental neuromotor disorders impair the efficacy of DIAm neuromuscular transmission, likely to contribute to respiratory complications.NEW & NOTEWORTHY Individuals with motor control deficits, including cerebral palsy (CP) often have respiratory impairments. Glycine-receptor mutant spa mice have early-onset hypertonia, and limb motor impairments, similar to individuals with CP. We hypothesized that in the diaphragm of spa mice, disruption of glycinergic inputs to MNs would result in increased phrenic-DIAm neuromuscular transmission failure. Pathophysiologic abnormalities in neuromuscular transmission may contribute to respiratory dysfunction in conditions where early developmental MN loss or motor control deficits are apparent.

Entities:  

Keywords:  cerebral palsy; innervation ratio; muscle specific force; neuromuscular junction; spasticity

Mesh:

Year:  2020        PMID: 33382958      PMCID: PMC7988788          DOI: 10.1152/japplphysiol.00864.2020

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  116 in total

1.  Influence of aminooxyacetic acid, a gamma-aminobutyrate transaminase inhibitor, on hereditary spastic defect in the mouse.

Authors:  C K CHAI; E ROBERTS; R L SIDMAN
Journal:  Proc Soc Exp Biol Med       Date:  1962-03

Review 2.  Adaptive and maladaptive motor axonal sprouting in aging and motoneuron disease.

Authors:  Tessa Gordon; Janka Hegedus; Siu Lin Tam
Journal:  Neurol Res       Date:  2004-03       Impact factor: 2.448

3.  Functional recovery of glycine receptors in spastic murine model of startle disease.

Authors:  Annamaria Molon; Simone Di Giovanni; Yetrib Hathout; Joanne Natale; Eric P Hoffman
Journal:  Neurobiol Dis       Date:  2005-09-22       Impact factor: 5.996

4.  Promotion of motoneuron survival and branching in rapsyn-deficient mice.

Authors:  G B Banks; T N Chau; S E Bartlett; P G Noakes
Journal:  J Comp Neurol       Date:  2001-01-01       Impact factor: 3.215

Review 5.  Evolution and Functional Differentiation of the Diaphragm Muscle of Mammals.

Authors:  Matthew J Fogarty; Gary C Sieck
Journal:  Compr Physiol       Date:  2019-03-14       Impact factor: 9.090

6.  Contractile characteristics and innervation ratio of rat soleus motor units.

Authors:  S Chamberlain; D M Lewis
Journal:  J Physiol       Date:  1989-05       Impact factor: 5.182

Review 7.  Respiratory problems in children with neurological impairment.

Authors:  P C Seddon; Y Khan
Journal:  Arch Dis Child       Date:  2003-01       Impact factor: 3.791

8.  Phrenic motor neuron loss in aged rats.

Authors:  Matthew J Fogarty; Tanya S Omar; Wen-Zhi Zhan; Carlos B Mantilla; Gary C Sieck
Journal:  J Neurophysiol       Date:  2018-02-07       Impact factor: 2.714

9.  Comparison of differences in respiratory function and pressure as a predominant abnormal movement of children with cerebral palsy.

Authors:  Hae-Yeon Kwon
Journal:  J Phys Ther Sci       Date:  2017-02-24

10.  Differences of respiratory function according to level of the gross motor function classification system in children with cerebral palsy.

Authors:  Yong Hyun Kwon; Hye Young Lee
Journal:  J Phys Ther Sci       Date:  2014-03-25
View more
  5 in total

1.  Mitochondrial adaptations to inactivity in diaphragm muscle fibers.

Authors:  Alyssa D Brown; Matthew J Fogarty; Leah A Davis; Debanjali Dasgupta; Carlos B Mantilla; Gary C Sieck
Journal:  J Appl Physiol (1985)       Date:  2022-06-09

2.  Diaphragm muscle function in a mouse model of early-onset spasticity.

Authors:  Matthew J Fogarty; Joline E Brandenburg; Wen-Zhi Zhan; Gary C Sieck
Journal:  J Appl Physiol (1985)       Date:  2022-05-19

3.  Impact of congenital diaphragmatic hernia on diaphragm muscle function in neonatal rats.

Authors:  Matthew J Fogarty; Elizabeth Ann L Enninga; Eniola R Ibirogba; Rodrigo Ruano; Gary C Sieck
Journal:  J Appl Physiol (1985)       Date:  2021-01-28

4.  Muscle-specific deletion of the vitamin D receptor in mice is associated with diaphragm muscle weakness.

Authors:  Matthew J Fogarty; Louis L Losbanos; Theodore A Craig; Carmen J Reynolds; Alyssa D Brown; Rajiv Kumar; Gary C Sieck
Journal:  J Appl Physiol (1985)       Date:  2021-05-20

5.  Tongue muscle contractile, fatigue, and fiber type properties in rats.

Authors:  Matthew J Fogarty; Gary C Sieck
Journal:  J Appl Physiol (1985)       Date:  2021-07-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.